Kitamura, Y., Kanaya, N., Moleirinho, S., Du, W., Reinshagen, C., Attia, N., . . . Shah, K. (2021). Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv.
Citação norma ChicagoKitamura, Yohei, et al. "Anti-EGFR VHH-armed Death Receptor Ligand–engineered Allogeneic Stem Cells Have Therapeutic Efficacy in Diverse Brain Metastatic Breast Cancers." Sci Adv 2021.
Citação norma MLAKitamura, Yohei, et al. "Anti-EGFR VHH-armed Death Receptor Ligand–engineered Allogeneic Stem Cells Have Therapeutic Efficacy in Diverse Brain Metastatic Breast Cancers." Sci Adv 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.